Yokoyama Minato, Nakanishi Yasukazu, Arisawa Chizuru, Ando Masao
Department of Urology, East Tokyo Metropolitan Hospital.
Hinyokika Kiyo. 2007 Mar;53(3):153-6.
The medical records of 8 consecutive patients with terminal urological cancers who were treated with implanted venous reservoirs between October 2001 and July 2004 were retrospectively reviewed. All 8 devices were placed safely in the 8 patients, and fluids and drugs were easily administered via the reservoirs. The devices were utilized for a mean of 40.6 days (range, 18 to 98) until the patients died of the cancer, and there were no complications which required removal of the devices such as catheter or reservoir infections, catheter occlusions and catheter thromboses. Seven patients were discharged or stayed at home on weekends and received home parental nutrition (HPN) through implanted venous reservoirs. Although HPN with the implanted venous reservoir is recently becoming common in digestive surgery or gynecological fields, it still remains uncommon in the urological field. Because this device would be useful and safe for patients with terminal urological cancers, we should consider the use of implanted venous reservoirs for patients who desire terminal home care.
对2001年10月至2004年7月间连续8例接受植入式静脉储器治疗的晚期泌尿系统癌症患者的病历进行回顾性研究。所有8个装置均安全植入8例患者体内,液体和药物可通过储器轻松给药。这些装置平均使用40.6天(范围18至98天),直至患者死于癌症,且未出现需要移除装置的并发症,如导管或储器感染、导管阻塞和导管血栓形成。7例患者出院或周末在家,通过植入式静脉储器接受家庭肠外营养(HPN)。尽管植入式静脉储器进行HPN在消化外科或妇科领域近来已很常见,但在泌尿外科领域仍不常见。由于该装置对晚期泌尿系统癌症患者有用且安全,对于希望接受终末期居家护理的患者,我们应考虑使用植入式静脉储器。